Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDR Gemcitabine + Capecitabine in Locally Advanced Pancreatic Cancer
NCT01268384Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Apr 2006
- Primary completion
- Jul 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, capecitabine in pancreatic adenocarcinoma (PDAC), sponsored by Asan Medical Center. Started Apr 2006; status: completed.
02
Drugs
gemcitabinecapecitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01268384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01268384.